These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 8077802)

  • 1. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury.
    Celik M; Gökmen N; Erbayraktar S; Akhisaroglu M; Konakc S; Ulukus C; Genc S; Genc K; Sagiroglu E; Cerami A; Brines M
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2258-63. PubMed ID: 11854521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of verapamil, gallopamil, diltiazem and nifedipine on sarcoplasmic reticulum function in rat heart.
    Zucchi R; Limbruno U; Ronca-Testoni S; Yu G; Galbani P; Ronca G; Mariani M
    Cardioscience; 1992 Sep; 3(3):167-72. PubMed ID: 1330045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists block angiotensin II-mediated vasoconstriction in humans: comparison with their effect on phenylephrine-induced vasoconstriction.
    Andrawis NS; Craft N; Abernethy DR
    J Pharmacol Exp Ther; 1992 Jun; 261(3):879-84. PubMed ID: 1602392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 release by erythropoietin involves calcium signaling in endothelial cells.
    Carlini RG; Gupta A; Liapis H; Rothstein M
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):889-92. PubMed ID: 8606524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 1,4-dihydropyridines with vasoconstrictor action through activation of Ca++-channels.
    Takenaka T; Inagaki O; Terai M; Asano M; Kubo K
    J Pharmacol Exp Ther; 1988 Feb; 244(2):699-708. PubMed ID: 2450201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium activation systems in vascular smooth muscle.
    Golenhofen K
    Bibl Anat; 1977; (15 Pt 1):123-5. PubMed ID: 597123
    [No Abstract]   [Full Text] [Related]  

  • 7. History of calcium antagonists.
    Fleckenstein A
    Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists. Some chemical-pharmacologic aspects.
    Triggle DJ; Swamy VC
    Circ Res; 1983 Feb; 52(2 Pt 2):I17-28. PubMed ID: 6299605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of erythropoietin on blood pressure.
    Raine AE; Roger SD
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):76-83. PubMed ID: 1928084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca-blockers and peripheral circulation--physiological viewpoints.
    Ekelund LG
    Acta Pharmacol Toxicol (Copenh); 1978; 43 Suppl 1():33-43. PubMed ID: 371334
    [No Abstract]   [Full Text] [Related]  

  • 11. Is erythropoietin-induced hypertension a phenomenon due to the intracellular Ca++ mobilisation?
    Buemi M; Allegra A; Laganà A; Aloisi C; Morabito N; Baldari S; Privitera M; Palella S; Imbesi D; Villari C
    Int Angiol; 1994 Mar; 13(1):75-7. PubMed ID: 8077802
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.